Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 142 publications
Impact of voxelotor discontinuation on patients with sickle cell disease.
Journal: British journal of haematology
Published: March 04, 2026
Renin-Angiotensin-Aldosterone System Inhibition Exacerbates Anemia in Sickle Cell Disease.
Journal: Blood
Published: February 20, 2026
Renin-angiotensin-aldosterone system inhibition exacerbates anemia in sickle cell disease.
Journal: Blood
Published: February 20, 2026
A Multicenter, Open-Label, Phase 2 Trial Comparing Crizanlizumab Combined With Standard Therapy to Standard Therapy Alone on Renal Function in Patients With Sickle Cell Nephropathy (STEADFAST).
Journal: American journal of hematology
Published: February 11, 2026
Circulating erythropoietin concentration associates with thromboembolism in sickle cell disease.
Journal: British journal of haematology
Published: January 12, 2026
The Longitudinal Effect of APOL1 Risk Alleles on Sickle Cell Anemia-Associated Kidney Function.
Journal: American journal of hematology
Published: December 29, 2025
Three-year safety, efficacy, and renal outcomes of mitapivat treatment in sickle cell disease: results from the phase 2 open-label study.
Journal: Haematologica
Published: September 02, 2025
Albuminuria Predicts a Rapid Decline in Kidney Function in 2 International, Longitudinal Cohorts of Adults With Sickle Cell Anemia.
Journal: American journal of hematology
Published: August 18, 2025
Increased Prevalence of Clonal Hematopoiesis in Children with Sickle Cell Disease.
Journal: Blood
Published: July 23, 2025
Increased prevalence of clonal hematopoiesis in children with sickle cell disease.
Journal: Blood
Published: July 23, 2025
Management of Kidney Disease with Sickle Cell Disease.
Journal: Journal of the American Society of Nephrology : JASN
Published: June 26, 2025
Last Updated: 09/26/2026